Dr. Matthew Siedhoff, MD
Claim this profileClinical Trials Matthew Siedhoff, MD is currently running
More about Matthew Siedhoff, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Matthew Siedhoff, MD has experience with
- Bupivacaine
- Oxycodone
Breakdown of trials Matthew Siedhoff, MD has run
Postoperative Pain
Free air in the abdominal cavity
Laparoscopic Surgery
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Siedhoff, MD specialize in?
Matthew Siedhoff, MD focuses on Postoperative Pain and Free air in the abdominal cavity. In particular, much of their work with Postoperative Pain has involved treating patients, or patients who are undergoing treatment.
Is Matthew Siedhoff, MD currently recruiting for clinical trials?
Yes, Matthew Siedhoff, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Matthew Siedhoff, MD has studied deeply?
Yes, Matthew Siedhoff, MD has studied treatments such as Bupivacaine, Oxycodone.
What is the best way to schedule an appointment with Matthew Siedhoff, MD?
Apply for one of the trials that Matthew Siedhoff, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.